Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)
Egypt
· Delayed Price · Currency is EGP 3.240
+0.160 (5.19%)
At close: Mar 5, 2026
EGX:SIPC Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 54.07 | 22.78 | 13.31 | 18.2 | 45.42 | 69.76 | Upgrade
|
| Revenue Growth (YoY) | 247.49% | 71.17% | -26.88% | -59.93% | -34.89% | 3.60% | Upgrade
|
| Cost of Revenue | 28.73 | 19.94 | 3.51 | 10.89 | 26.67 | 30.03 | Upgrade
|
| Gross Profit | 25.34 | 2.84 | 9.8 | 7.31 | 18.75 | 39.73 | Upgrade
|
| Selling, General & Admin | 6.27 | 6.29 | 6.48 | 5.72 | 9.85 | 19.25 | Upgrade
|
| Other Operating Expenses | 3.11 | 0.99 | -0.04 | - | - | - | Upgrade
|
| Operating Expenses | 15.85 | 13.7 | 6.45 | 5.73 | 9.9 | 19.5 | Upgrade
|
| Operating Income | 9.49 | -10.86 | 3.34 | 1.58 | 8.85 | 20.23 | Upgrade
|
| Interest Expense | -2.24 | -1.2 | -1.05 | -1.07 | -0.65 | -0.66 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.69 | -8.66 | -0.62 | 0 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.12 | 2.12 | 0.5 | 0.44 | 0.62 | - | Upgrade
|
| Pretax Income | 10.06 | -18.61 | 2.18 | 0.96 | 8.81 | 19.56 | Upgrade
|
| Income Tax Expense | -3.77 | -0.57 | 1.02 | 0.94 | 2.03 | 4.42 | Upgrade
|
| Net Income | 13.83 | -18.04 | 1.16 | 0.02 | 6.78 | 15.14 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | 0.12 | 0 | 1.29 | 3.11 | Upgrade
|
| Net Income to Common | 13.83 | -18.04 | 1.04 | 0.01 | 5.49 | 12.04 | Upgrade
|
| Net Income Growth | - | - | 6280.77% | -99.73% | -55.22% | 76.28% | Upgrade
|
| Shares Outstanding (Basic) | 250 | 250 | 250 | 250 | 250 | - | Upgrade
|
| Shares Outstanding (Diluted) | 250 | 250 | 250 | 250 | 250 | - | Upgrade
|
| EPS (Basic) | 0.06 | -0.07 | 0.00 | 0.00 | 0.02 | - | Upgrade
|
| EPS (Diluted) | 0.06 | -0.07 | 0.00 | 0.00 | 0.02 | - | Upgrade
|
| EPS Growth | - | - | 7075.86% | -99.74% | - | - | Upgrade
|
| Free Cash Flow | -5.71 | -2.08 | 2.09 | -17.29 | 3.44 | -15.25 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.01 | 0.01 | -0.07 | 0.01 | - | Upgrade
|
| Gross Margin | 46.87% | 12.47% | 73.63% | 40.17% | 41.28% | 56.95% | Upgrade
|
| Operating Margin | 17.55% | -47.68% | 25.13% | 8.70% | 19.48% | 29.00% | Upgrade
|
| Profit Margin | 25.58% | -79.19% | 7.82% | 0.08% | 12.09% | 17.26% | Upgrade
|
| Free Cash Flow Margin | -10.57% | -9.14% | 15.72% | -94.97% | 7.57% | -21.86% | Upgrade
|
| EBITDA | 13.09 | -7.77 | 6.56 | 5.4 | 12.06 | 22.6 | Upgrade
|
| EBITDA Margin | 24.21% | -34.10% | 49.31% | 29.68% | 26.55% | 32.40% | Upgrade
|
| D&A For EBITDA | 3.6 | 3.09 | 3.22 | 3.82 | 3.21 | 2.38 | Upgrade
|
| EBIT | 9.49 | -10.86 | 3.34 | 1.58 | 8.85 | 20.23 | Upgrade
|
| EBIT Margin | 17.55% | -47.68% | 25.13% | 8.70% | 19.48% | 29.00% | Upgrade
|
| Effective Tax Rate | - | - | 46.88% | 98.11% | 23.04% | 22.60% | Upgrade
|
| Advertising Expenses | - | 0 | 0 | 0.03 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.